Unexpected mental health impact of GLP-1 medications

Now, you can probably list the potential franchises to go to GLP-1 receptor agonist such as Ozempic or Zepbound In your sleep. These medications can support blood sugar control, weight loss, and cardiovascular health, among many other things — and this is probably nothing new to you. But the messaging around GLP-1s and mental health has been a bit confusing.

When these medications first became popular, there was a lot of public commentary claiming that taking GLP-1 was associated with an increased risk of suicide. Which sparked an investigation before Food and Drug Administration (FDA), although the agency noted in January that a preliminary evaluation of the data found no evidence that GLP-1 causes suicidal thoughts or actions.

Now, new research suggests that taking GLP-1 can have a big impact on your mental health, in a good way.

Before we dive in, let’s address the big question: No, doctors aren’t suggesting you rush out and get GLP-1 if you’re suffering from depression or anxiety. But health care providers are excited about the possibility of another treatment option for people with these conditions, provided you need GLP-1 in the first place. Here’s the deal.

This study is a huge win for GLP-1 and mental health.

For the study published in Lancet PsychiatryThe researchers analyzed data from nearly 100,000 participants who were followed through Swedish national registries between 2009 and 2022. Of these, more than 20,000 participants used GLP-1 medications.

And the researchers found that People who have used GLP-1 medications– Especially semaglutide (the active ingredient in Ozempic and Wegovy) – they had a 42% lower risk of becoming ill and needing hospital care for psychiatric reasons than when they were not taking the drug. The researchers also found that semaglutide users with depression had a 44% lower risk, while those with anxiety disorders had a 38% lower risk. There was also a lower risk of suicidal behavior in people who used GLP-1s overall.

Semaglutide had an impact on substance use disorders as well, with people taking semaglutide being 47% less likely to become ill or hospitalized due to drug use.

“People who suffer from diabetes and obesity He owns High rates From depression, anxiety and suicide. Mark Taylor, MBBSStudy co-author and psychiatrist from Griffith University tells SELF. “The reduction in sick leave, or health-related absences from work, was an unexpected and very important finding, along with a reduction in suicidal behaviours. As mental health is now the most common reason people are on sick leave, or miss work due to ill health, this has major public health implications.”